The objective of this project is to investigate the mechanisms by which the cell-mediated immune response (CMI) in the lung is impaired by severe protein-calorie deficiency (PCM). A well-defined rat model will be used to study the effects of PCM on host defenses against aerosolized L. monocytogenes, a prototype of an organism handled by cell-mediated immunity.
The specific aims are to determine: 1) whether PCM impairs alveolar macrophage (AM) antigen recognition and antigen presentation to lymphocytes; 2) whether PCM affects the phenotypic populations of resident lymphocytes in lung and spleen, or the changes in these populations which occur after inhalation of a bacterial antigen (L. monocytogenes); 3) whether PCM impairs interleukin-1 production by AM and splenic macrophages; 4) whether PCM impairs interleukin-2 production by T lymphocytes, or whether PCM impairs the lymphocyte proliferative response to interleukin-2; 5) whether PCM affects AM and splenic macrophage activation; 6) whether PCM impairs the generation of AM of inflammatory mediators derived from arachidonic acid; 7) whether resistance to L. monocytogenes in protein-deficient animals can be restored by adoptive transfer of macrophages and/or lymphocytes from listeria-exposed normal animals. Before and after listeria exposure in control, pair-fed and PCM animals, measurements will be made of macrophage antigen presentation to lymphocytes, interleukin-1 an interleukin-2 production, macrophage activation, and macrophage arachidonic acid metabolism. Pulmonary and splenic macrophages and lymphocytes will be used to compare regional responses in the lung with systemic responses. Adoptive transfer experiments will be performed to determine the combinations of cell populations necessary to reconstitute the immune defenses of the PCM animals. This project will yield information about the mechanism(s) by which PCM, a host factor which is common worldwide, affects the expression of cell-mediated immunity within the lung.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033247-03
Application #
3344919
Study Section
Pathology A Study Section (PTHA)
Project Start
1984-12-01
Project End
1988-05-30
Budget Start
1986-12-01
Budget End
1988-05-30
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Goodman, R B; Forstrom, J W; Osborn, S G et al. (1991) Identification of two neutrophil chemotactic peptides produced by porcine alveolar macrophages. J Biol Chem 266:8455-63
Martin, T R; Pistorese, B P; Hudson, L D et al. (1991) The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am Rev Respir Dis 144:254-62
Skerrett, S J; Henderson, W R; Martin, T R (1990) Alveolar macrophage function in rats with severe protein calorie malnutrition. Arachidonic acid metabolism, cytokine release, and antimicrobial activity. J Immunol 144:1052-61
Skerrett, S J; Schmidt, R A; Martin, T R (1989) Impaired clearance of aerosolized Legionella pneumophila in corticosteroid-treated rats: a model of Legionnaires' disease in the compromised host. J Infect Dis 160:261-73
Martin, T R; Pistorese, B P; Chi, E Y et al. (1989) Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 84:1609-19
Martin, T R; Rubens, C E; Wilson, C B (1988) Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis 157:91-100
Martin, T R; Raugi, G; Merritt, T L et al. (1987) Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Invest 80:1114-24
Martin, T R (1986) Arachidonic acid metabolism in lung phagocytes. Semin Respir Infect 1:89-98